Hyunsoo Cho Selected Research

Translationally-Controlled 1 Tumor Protein

8/2022	Dimeric translationally controlled tumor protein-binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells.
12/2021	dTBP2 attenuates severe airway inflammation by blocking inflammatory cellular network mediated by dTCTP.
1/2021	Allergic Inflammation Caused by Dimerized Translationally Controlled Tumor Protein is Attenuated by Cardamonin.
1/2021	Dimerized Translationally Controlled Tumor Protein-Binding Peptide 2 Attenuates Systemic Anaphylactic Reactions Through Direct Suppression of Mast Cell Degranulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyunsoo Cho Research Topics

Disease

6	Multiple Myeloma 01/2022 - 01/2016
5	Inflammation (Inflammations) 08/2022 - 01/2020
3	Asthma (Bronchial Asthma) 08/2022 - 01/2021
3	Neoplasms (Cancer) 12/2019 - 03/2016
3	Lymphoma (Lymphomas) 10/2018 - 01/2016
2	Ganglion Cysts (Ganglion) 01/2021 - 01/2021
1	Skin Diseases (Skin Disease) 08/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2022
1	Rhinitis 08/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2022
1	Bone Resorption 07/2021
1	Tooth Avulsion 07/2021
1	Allergic Rhinitis 01/2021
1	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Glaucoma 01/2021
1	Insulin Resistance 12/2018
1	Obesity 12/2018
1	Overnutrition 12/2018
1	Hepatitis 10/2018
1	Hepatitis B 10/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2017
1	Immunoglobulin Light-chain Amyloidosis 01/2017
1	Bacterial Infections (Bacterial Infection) 04/2016
1	Lymphopenia (Lymphocytopenia) 04/2016
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Febrile Neutropenia 03/2016
1	Endocarditis 03/2014
1	Hemorrhage 03/2009

Drug/Important Bio-Agent (IBA)

4	Translationally-Controlled 1 Tumor ProteinIBA 08/2022 - 01/2021
3	dimeric TCTP-binding peptide 2IBA 08/2022 - 01/2021
3	CytokinesIBA 08/2022 - 01/2020
3	Peptides (Polypeptides)IBA 08/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2017
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 01/2016
1	Imiquimod (Aldara)FDA LinkGeneric 08/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Interleukin-17 (Interleukin 17)IBA 12/2021
1	LipopolysaccharidesIBA 12/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 07/2021
1	cardamoninIBA 01/2021
1	daratumumabIBA 01/2021
1	AllergensIBA 01/2021
1	p-Methoxy-N-methylphenethylamineIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 12/2019
1	Long-Acting Thyroid Stimulator (LATS)IBA 12/2019
1	LipidsIBA 12/2018
1	rho-Associated KinasesIBA 12/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2018
1	LigandsIBA 10/2017
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2017
1	Bortezomib (Velcade)FDA Link 04/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Docetaxel (Taxotere)FDA Link 03/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2014
1	Factor V (Coagulation Factor V)IBA 03/2009
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2009
1	AntigensIBA 03/2009

Therapy/Procedure

5	Therapeutics 08/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 10/2018 - 01/2016
3	Stem Cell Transplantation 10/2018 - 01/2016
1	Tooth Replantation 07/2021
1	Adjuvant Chemotherapy 03/2016
1	Induction Chemotherapy 01/2016
1	Hematopoietic Stem Cell Mobilization 01/2016
1	Tooth Extraction (Tooth Extractions) 03/2009